Tomorrow, October 3, PhRMA will convene health care leaders for a discussion on how we can move our health care system toward one focused on value rather than volume, ensuring patients can access the new era of medicine that is changing the treatment paradigm for some of our costliest and most challenging diseases. This event, Leading on Value: Solutions for an Evolving Health Care System, is held in partnership with The Economist Group.
Over the last several years, a growing interest by U.S. health care stakeholders to engage in value-based reimbursement models has accelerated the movement toward high-value care. For biopharmaceutical companies, this means sharing greater financial risk with payers through flexible payment arrangements that tie payment for medicines to how well they work for patients. These innovative payment models – referred to as value-based or results-based contracts – hold significant promise in reducing costs for patients and the health system.
The event will include an interview between Amgen Chairman and CEO Robert Bradway and former Centers for Medicare & Medicaid Services acting administrator Leslie Norwalk as well as a keynote interview with Seema Verma, administrator of the Centers for Medicare & Medicaid Services. Additionally, a diverse panel of health care executives, including Sanofi CEO Olivier Brandicourt, will discuss how the changing nature of biopharmaceutical innovation – with its greater focus on cures and personalized medicines – requires fresh thinking on how we define and assess value for patients.
We’ve made progress in our quest to drive greater value for U.S. patients, but we still need more solutions that will lower out-of-pocket costs, improve patient affordability and create an environment that fosters and sustains innovation for years to come.
Join us online on Wednesday, October 3, from 8:30 a.m. to 10:10 a.m. EST to hear from these leading voices in health care.